Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Krause, D.N. and Dubocovich, M.L. Regulatory sites in the melatonin system of mammals. Trends Neurosci 13:464–470, 1990.
Reiter, R.J. Pineal melatonin: cell biology of its synthesis and its physiological interactions. Endocr Rev 12:151–180, 1991.
McCord, C.P. and Allen, F.P. Evidence associating pineal gland function with alterations in pigmentation. J Exp Zool 23:207–224, 1917.
Lerner, A.B., Case, J.D., and Heizelman, R.V. Structure of melatonin. J Am Chem Soc 81:6084–6085, 1959.
Heward, C.B. and Hadley, M.E. Structure-activity relationships of melatonin and related indoleamines. Life Sci 17:1167–1178, 1975.
White, B.H., Sekura, R.D., and Rollag, M.D. Pertussis toxin blocks melatonin induced pigment aggregation in Xenopus dermal melanophores. J Comp Physiol 157:153–159, 1987.
Ebisawa, T., Karne, S., Lerner, M.R., and Reppert, S.M. Expression cloning of a high affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 91:6133–6137, 1994.
Reppert, S.M., Weaver, D.R., and Godson, C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 17:100–102, 1996.
Dubocovich, M.L. Melatonin is a potent modulator of dopamine release in the retina. Nature 306:782–784, 1983.
Dubocovich, M.L. Characterization of a retinal melatonin receptor. J Pharmacol Exp Ther 234:395–401, 1985.
Dubocovich, M.L. Luzindole (N-0774): A novel melatonin receptor antagonist. J Pharmac Exp Ther 246:902–910, 1988.
Dubocovich, M.L. Pharmacology and function of melatonin receptors. FASEB J 2:2765–2773,1988.
Dubocovich, M.L. Pharmacology and function of melatonin in retina. Osborne, N.N. and Chader, G. Progress in Retinal Research. Oxford, Pergamon Press 8:129–151, 1988.
Dubocovich, M.L. Melatonin receptors: Are There Multiple Subtypes? Trends Pharmacol Sci 16:50–56, 1995.
Vakkuri, O., Leppaluoto, J., and Vuolteenaho, O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol (Copenh) 106:152–157, 1984.
Dubocovich, M.L. and Takahashi, J.S. Use of 2-[125I]-iodomelatonin to characterize melatonin binding sites in chicken retina. Proc Natl Acad Sci USA 84:3916–3920, 1987.
Morgan, P.J., Barrett, P., Howell, H.E., and Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 24:101–146, 1994.
Dubocovich, M.L., Benloucif, S., and Masana, M.I. Melatonin receptors in the mammalian suprachiasmatic nucleus. Behav Brain Res 73:141–147, 1996.
Reppert, S.M., Weaver, D.R., Rivkees, S.A., and Stopa, E.G. Putative melatonin receptors in a human biological clock. Science 242:78–81, 1988.
Armstrong, S.M. and Redman, J.R. Melatonin and circadian rhythmicity. Yu, H.S., and Reiter, R.J. In Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications. CRC Press 187–224, 1993.
Weaver, D.R. and Reppert, S.M. The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei. NeuroReport 8:109–112, 1996.
Mahle, C.D., Goggins, G.D., Agarwal, P., Ryan, E., and Watson, A.J. Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 12:690–696, 1997.
Dubocovich, M.L., Cardinali, D.P., Guardiola-Lemaitre, B., Hagan, R.M., Krause, D.N., Sugden, D., Vanhoutte, PM., and Yocca, F.D. Melatonin receptors. The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, London, pp 187–193, 1998.
Dubocovich, M.L., Masana, M.I., Iacob, S., and Sauri, D.M. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiederbergs’ Arch Pharmacol355:365–375, 1997.
Dubocovich, M.L., Yun, K., Al-Ghoul, W., Benloucif, S., and Masana, M.I. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB 12:1211–1220, 1998.
Slaugenhaupt, S.A., Roca, A.L., Liebert, C.B., Altherr, M.R., Gusella, J.F., and Reppert, S.M. Mapping of the gene for the Mel1a melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (MTNR1a). Genomics 27:355–357, 1995.
Godson, C. and Reppert, S.M. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138:397–404, 1997.
Witt-Enderby, P.A. and Dubocovich, M.L. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol Pharrnacol 50:16–174, 1996.
Vacas, M.I., Keller-Sarmiento, M.I., and Cardinali, D.P. Melatonin increases cGMP and decreases cAMP levels in the medial basal hypothalamus in vitro. Brain Res 225:207–211, 1982.
Vanecek, J. and Klein, D.C. Mechanism of melatonin signal transduction in the neonatal rat pituitary. Neurochem Int 27:273–278, 1995.
Jiang, Z.-G., Nelson, C.S., and Allen, C.N. Melatonin activates an outward current and inhibits I h in rat suprachiasmatic nucleus neurons. Brain Research 687:125–132, 1995.
Geary, G.G., Krause, D.N., and Duckles, S.P. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol 273:H1530–H1536, 1997.
Duncan, M.J., Takahashi, J.S., and Dubocovich, M.L. Characteristics and autoradiographic localization of 2-[125I]-iodomelatonin binding sites in Djungarian hamster brain. Endocrinology 125:1011–1018, 1989.
Molinari, E.J., North, P.C., and Dubocovich, M.L. Characterization of ML2 melatonin binding sites using the selective radioligand 2-[125I]-iodo-5-methoxycarbonylamino-N-acetyltryptamine. Eur J Pharmacol 301:159–168, 1996.
Pickering, D.S. and Niles, L.P Expression of nanomolar-affinity binding sites for melatonin in Syrian hamster RPMI 1846 melanoma cells. Cell Sig 4:201–207, 1992.
Le Gouic, S., Atgie, C., Viguerie-Bascands, N., Hanoun, N., Larrouy, D., Ambid, L., Raimbault, S., Ricquier, D., Delagrange, P., Guardiola-Lemaitre, B., Penicaud, L., and Casteilla, L. Characterization of a melatonin binding site in Siberian hamster brown adipose tissue. Eur J Pharmacol 339:271–278, 1997.
Popova, J.S. and Dubocovich, M.L. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J Neurochem 64:130–138, 1995.
Lucchelli, A., Santagostino-Barbone, M.G., and Tonini, M. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors. Br J Pharrnacol 121:1775–1781, 1997.
Beresford, I.J.M., North, P.C., Oakley, N.R., Starkey, S., Brown, J., Foord, S.M., Andrews, J., Coughlan, J., Stratton, S., Dubocovich, M.L., and Hagan, R.M. GR 196429: A nonindolic agonist at high-affinity melatonin receptors. J Pharmacol Exp Ther 285:1239–1245, 1998.
Ying, S.-H., Rusak, B., Delagrange, P., Mocaer, E., Renard, P., and Guardiola-Lemaitre, B. Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 296:33–42, 1996.
Liu, C., Weaver, D.R., Jin, X., Shearman, L.P., Pieschl, R.L., Gribkoff, V.K., and Reppert, S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91–102, 1997.
McArthur, J.J., Hunt, A.E., and Gillette, M.U. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627–634, 1997.
Starkey, S.J., Walker, M.P., Beresford, I.J.M., and Hagan, R.M. Modulation of the rat suprachiasmatic circadian clock by melatonin in vitro. Neuroreport 6:1947–1951, 1995.
Goto, M., Oshima, I., Tomita, T., and Ebihara, S. Melatonin content of the pineal gland in different mouse strains. J Pineal Res 7:195–204, 1989.
Benloucif, S. and Dubocovich, M.L. Melatonin and light induce phase shifts of circadian rhythms in the C3H/HeN mouse. J Biol Rhythms 11:113–125, 1996.
Lewy, A.J., Ahmed, S., Latham-Jackson, J.M., and Sack, R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 9, 380–392, 1992.
Doolen, S., Krause, D., Dubocovich, M., and Duckles, S. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345:67–69, 1998.
Mazzucchelli, C., Pannacci, M., Nonno, R., Lucini, V., Fraschini, F., and Stankov, B.M. The melatonin receptor in the human brain: cloning experiments and distribution studies. Mol Brain Res 39:117–126, 1996.
Zhdanova, I.V., Wurtman, R.J., Lynch, H.J., Ives, J.R., Dollins, A.B., C, M., Matheson, J.K., and Schomer, D.L. Pharmacodynamics and drug action: Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 57:552–558, 1995.
Wirz-Justice, A. Biological rhythms in mood disorders. In Pharmacology: The Fourth Generation of Progress (Bloom, F.E. and Kupfer, D.J., eds) pp. 999–1017, Raven Press, Ltd., New York, 1995.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Dubocovich, M.L., Masana, M.I., Benloucif, S. (2002). Molecular Pharmacology and Function Ofmelatonin Receptor Subtypes. In: Olcese, J. (eds) Melatonin After Four Decades. Advances in Experimental Medicine and Biology, vol 460. Springer, Boston, MA. https://doi.org/10.1007/0-306-46814-X_20
Download citation
DOI: https://doi.org/10.1007/0-306-46814-X_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46134-7
Online ISBN: 978-0-306-46814-8
eBook Packages: Springer Book Archive